Akiho H et al. Role of inflammation in IBS
organs including the gut and brain and is an important determinant of normal function in these systems. Dis-ruption of the delicate balance between the host and the intestinal microbiota (termed dysbiosis) results in changes in the mucosal immune system that range from overt inflammation, as seen in Crohn’s disease, to low-grade inflammation without tissue injury, as seen in a subset of IBS patients. The dysbiosis induced by infection, diet or antibiotics can produce the low-grade inflammation seen in IBS[41]. Malinen et al[42] showed that Lactobacillus species were decreased in IBS-D patients while Veionella species were increased in IBS-C patients.
Other groups have obtained evidence that the in-testinal microflora of patients with IBS differs from that of healthy subjects[43,44]. It has recently been suggested that IBS symptoms are partly caused by a process designated small intestinal bacterial overgrowth (SIBO)[45,46]. Fur-ther therapeutic manipulation of the gut flora with anti-biotics[47] or probiotics[48] improves the symptoms of IBS but is controversial. We consider SIBO as a subtype of IBS more than a distinct entity.
These lines of evidence provide proof of the con-cept that the intestinal microbiota can induce the persis-tent gut dysfunction seen in IBS.
phosphatase inhibitor protein-17 kDa (CPI-17). In ad-dition, it has been shown that mitogen activated protein kinase pathways also contribute to intestinal smooth muscle contraction and Ca2+ sensitization possibly via regulation of MLCP[56].
GUT MOTOR FUNCTION IN INFLAMMATION
Conditions ranging from infective acute enteritis or colitis to IBD and functional disorders such as IBS are accom-panied by altered GI motility[57] which can be a reflection of altered function of enteric nerves, ICC or smooth muscles. Alterations in GI motility with resultant changes in transit contribute to the abdominal pain, intestinal cramping and diarrhea. Colonic mast cell infiltration and mediator release in the proximity of mucosal innervations may contribute to abdominal pain perception in patients with IBS[13]. Patients with IBD in remission often generate IBS symptoms, termed IBD/IBS, and have pain and diar-rhea similar to those in IBS patients in association with minimal or no evident intestinal inflammation[58].
These findings suggest that low-grade inflammation contributes to the GI motor dysfunction and abdominal symptoms in patients with functional GI disorders and IBD in remission. Since we cannot use whole human intestinal tissue to investigate the pathophysiology of IBS, we have tried to establish bench-to-bedside animal models for the development of new therapies.
Which immune cells and mediators and how do they affect gastrointestinal motility?
Macrophages: Macrophages perform a key role in innate defense against foreign invaders and produce a number of cytokines such as IL-1β, IL-6 and TNF-α. In animal experiments, macrophages infiltrate the gut wall including the neuromuscular layers during nematode infection in mice. It was reported that macrophages were not critical for the change in muscle contraction in Trichinella spiralis-infected mice[59] although another group reported that alternative activated macrophages affected the muscle hypercontractility in Nippostrongylus brasiliensis-infected mice[60].
T lymphocytes (Th1/Th2): T lymphocytes are crucial for many immune responses, including those associated with animal models such as dextran sulfate sodium coli-tis[61], 2,4,6-trinitrobenzenesulfonic acid colitis[62], nema-tode infection[57,63] and anti-CD3 antibody-induced en-teropathy[64]. Antigen-presenting cells present antigens to CD4+ T helper (Th) cells. Th cell-dependent immune re-sponses are generally divided into two major subsets, Th1 and Th2[65]. Th1 cells predominantly produce interferon (IFN) γ and IL-2 while Th2 cells produce IL-4, IL-5, IL-9 and IL-13. Th1 and Th2 cells cross-regulate one another. While few generalizations can be made, it appears that contractile dysfunction depends on the specific inflamma-tory environment. Recent accumulated data from animal
GI MOTILITY AND SMOOTH MUSCLE
GI motility is defined by the movements of the digestive system including two fundamental patterns of motility, propulsion and mixing. Several players including central nerves, enteric nerves, interstitial cells of Cajal (ICC) and smooth muscles contribute to a coordinated regulation of GI motility. Among them, smooth muscle probably plays the most important role in GI motility since the patterns of motility observed in gut are characteristic of smooth muscle which has different properties from skeletal muscle. The contractile properties of smooth muscle are mainly regulated by the phosphorylation of regulatory light chains of myosin Ⅱ (LC20)[49] which is driven by the balance between myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activities. MLCK depends on Ca2+-calmodulin. Intracellular Ca2+ [(Ca2+)i] is the primary determinant of smooth muscle contraction. However, MLCP functions independently of Ca2+-calmodulin and is regulated by G protein-coupled signaling pathways. Inhibition of MLCP leads to an increase in both MLC phosphorylation and contractile force development in smooth muscle without any changes in (Ca2+)i[50]. This enhancement of the contractile response to Ca2+ is commonly referred to as 'calcium sensitization'[49]. In general, several protein kinases including Rho-associated kinase (ROK)[51], protein kinase C (PKC)[52], integrin-linked kinase (ILK)[53,54] and zipper-interacting protein kinase (ZIPK)[55] have been shown to contribute to regulation of MLCP and Ca2+ sensitization, mediated directly by phosphorylation of the myosin phosphatase targeting subunit of MLCP (MYPT1) and/or indirectly by phosphorylation of a PKC-potentiated
of the gastrocolic reflex and lessen pain, discomfort, and bowel dysfunction... placebo in the treatment of all three forms of irritable bowel syndrome. ...
Controversies and limitations in irritable bowel syndrome studies_专业资料。维普资讯 http://www.cqvip.com Cieedclora07102)1324 hns i unl0;2(3:4—15 ...
Chapter 10 Psychological Factors and Treatments in Irritable Bowel Syndrome (... there may be no evident psychological correlates of dysfunction and patients...
irritable-bowel-syndrome_英语学习_外语学习_教育... central neural dysfunction, stress, and ...Gastroenteritis may predispose IBS in 25% of ...
The utility of diagnostic tests in irritable bowel syndrome patients: a ... at bedtime Sexual dysfunction, headache, nausea, sedation, insomnia, ...
【国家自然科学基金】_irritable bowel syndrome_期刊发文热词逐年推荐_20140729_英语学习_外语学习_教育专区。2008年 序号 1 2 3 4 5 6 7 8 9 10 11 12 ...
Characterization of auto2 D nomic dysfunction in patients with irritable bowel syndrome by · 文摘· 艺术体操运动员跳跃 、、 提踵 转体动作时间密度统计分析...
in IBD, may lead to pelvic floor dysfunction (PFD) in patients with IBD...Irritable bowel syndrome: a real association or reflection of occult ...
thyroid dysfunction 暂无评价 5页 1财富值 Erectile Dysfunction 暂无评价 356...Anesthesia in Irritable Bowel Syndrome (IBS) Patients Lene Vase, Donald D....
D efecatory dysfunction is common in women, but is often underrecognized and...cIBS = constipation-predominant irritable bowel syndrome. multiple classes of ...
热门文档